Headache associated with COVID-19: Frequency, characteristics and association with anosmia and ageusia
- PMID: 33146035
- PMCID: PMC7645592
- DOI: 10.1177/0333102420966770
Headache associated with COVID-19: Frequency, characteristics and association with anosmia and ageusia
Abstract
Objectives: To assess the frequency and characteristics of headache in patients with COVID-19 and whether there is an association between headache and anosmia and ageusia.
Methods: This was a cross-sectional study. Consecutive patients admitted to hospital with COVID-19, confirmed by reverse transcription polymerase chain reaction (RT-PCR) technique, were assessed by neurologists.
Results: Seventy-three patients were included in the study, 63% were male; the median age was 58 years (IQR: 47-66). Forty-seven patients (64.4%) reported headaches, which had most frequently begun on the first day of symptoms, were bilateral (94%), presenting severe intensity (53%) and a migraine phenotype (51%). Twelve patients (16.4%) presented with headache triggered by coughing. Eleven (15%) patients reported a continuous headache. Twenty-eight patients (38.4%) presented with anosmia and 29 (39.7%) with ageusia. Patients who reported hyposmia/anosmia and/or hypogeusia/ageusia experienced headache more frequently than those without these symptoms (OR: 5.39; 95% CI:1.66-17.45; logistic regression). Patients with anosmia and ageusia presented headache associated with phonophobia more often compared to those with headache without these complaints (Chi-square test; p < 0.05). Headache associated with COVID-19 presented a migraine phenotype more frequently in those experiencing previous migraine (p < 0.05).
Conclusion: Headaches associated with COVID-19 are frequent, are generally severe, diffuse, present a migraine phenotype and are associated with anosmia and ageusia.
Keywords: COVID-19; Headache; SARS-CoV-2; ageusia; anosmia; olfaction disorders.
Conflict of interest statement
Similar articles
-
Potential pathogenesis of ageusia and anosmia in COVID-19 patients.Int Forum Allergy Rhinol. 2020 Sep;10(9):1103-1104. doi: 10.1002/alr.22593. Epub 2020 Jun 15. Int Forum Allergy Rhinol. 2020. PMID: 32342636 Free PMC article. Review. No abstract available.
-
Association of COVID-19 with Anosmia and Hypogeusia.Am J Med Sci. 2020 Oct;360(4):414. doi: 10.1016/j.amjms.2020.06.012. Epub 2020 Jun 12. Am J Med Sci. 2020. PMID: 32703532 Free PMC article. No abstract available.
-
Ageusia and anosmia, a common sign of COVID-19? A case series from four countries.J Neurovirol. 2020 Oct;26(5):785-789. doi: 10.1007/s13365-020-00875-8. Epub 2020 Jul 14. J Neurovirol. 2020. PMID: 32666422 Free PMC article.
-
[Anosmia and ageusia as primary symptoms of COVID-19].Ugeskr Laeger. 2020 Apr 27;182(18):V04200205. Ugeskr Laeger. 2020. PMID: 32400371 Danish.
-
Importance of SARs-Cov-2 anosmia: From phenomenology to neurobiology.Compr Psychiatry. 2020 Jul;100:152184. doi: 10.1016/j.comppsych.2020.152184. Epub 2020 May 11. Compr Psychiatry. 2020. PMID: 32422426 Free PMC article. Review.
Cited by
-
Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review.Eur J Neurol. 2024 Jun;31(6):e16251. doi: 10.1111/ene.16251. Epub 2024 Feb 28. Eur J Neurol. 2024. PMID: 38415282 Free PMC article.
-
Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study.J Headache Pain. 2022 Jan 3;23(1):2. doi: 10.1186/s10194-021-01367-8. J Headache Pain. 2022. PMID: 34979899 Free PMC article.
-
Prevalence, Patterns, Prognosis, and Psychosocial Impact of Olfactory and Gustative Dysfunctions Among Saudi COVID-19 Patients.Cureus. 2022 Nov 21;14(11):e31743. doi: 10.7759/cureus.31743. eCollection 2022 Nov. Cureus. 2022. PMID: 36569668 Free PMC article.
-
Neurologic Manifestations of Coronavirus Disease 2019 in Children: An Iranian Hospital-Based Study.Arch Iran Med. 2023 Mar 1;26(3):166-171. doi: 10.34172/aim.2023.25. Arch Iran Med. 2023. PMID: 37543939 Free PMC article.
-
NEURO-COVAX: An Italian Population-Based Study of Neurological Complications after COVID-19 Vaccinations.Vaccines (Basel). 2023 Oct 21;11(10):1621. doi: 10.3390/vaccines11101621. Vaccines (Basel). 2023. PMID: 37897023 Free PMC article.
References
-
- Lippi G, Mattiuzzi C, Bovo C, et al. Headache is an important symptom in patients with coronavirus disease 2019 (COVID-19). Diagnosis. Epub ahead of print 2 June 2020. DOI: 10.1515/dx-2020-0048. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous